SCHEMBL5215671

SCHEMBL5215671

O=C(c1cccc([N+](=O)[O-])c1)C1CCNCC1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.57
CES1 P23141 1/20 0.57
MGLL Q99685 1/20 0.56
HSD11B1 P28845 1/20 0.56
TP53 P04637 1/20 0.55
ALDH1A1 P00352 4/20 0.54
TSHR P16473 2/20 0.54
POLB P06746 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPT P10636 1/20 0.48
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
CYP2D6 P10635 1/20 0.48
OPRM1 P35372 1/20 0.47
OPRD1 P41143 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5210218 0.99 CES2 (0.55) CES2CES1MGLLHSD11B1TP53
SCHEMBL29433469 0.91 CES2 (0.64) CES2CES1MGLLHSD11B1TP53
SCHEMBL6175481 0.91 CES2 (0.64) CES2CES1MGLLHSD11B1TP53
SCHEMBL29408246 0.88 CES2 (0.60) CES2CES1MGLLHSD11B1TP53
SCHEMBL22658456 0.88 ALDH1A1 (0.61) CES2CES1MGLLHSD11B1TP53
SCHEMBL29433310 0.88 ALDH1A1 (0.61) CES2CES1MGLLHSD11B1TP53
SCHEMBL22658096 0.88 CES2 (0.60) CES2CES1MGLLHSD11B1TP53
Bicarbonate SCHEMBL11470070 0.87 TP53 (0.61) CES2CES1MGLLHSD11B1TP53
SCHEMBL7785407 0.87 ALDH1A1 (0.63) CES2CES1MGLLHSD11B1TP53
Bicarbonate SCHEMBL6614524 0.84 ALDH1A1 (0.60) CES2CES1MGLLHSD11B1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1153013-B1 5-HT1F AGONISTS LILLY CO ELI (US) 2007-10-31 EP claimed
US-6777428-B1 INHIBIT PEPTIDE EXTRAVASATION DUE TO STIMULATION OF THE TRIGEMINAL GANGLIA, AND ARE THEREFORE USEFUL FOR THE TREATMENT OF MIGRAINE AND ASSOCIATED DISORDERS ELI LILLY AND COMPANY 2004-08-17 US claimed
EP-1153013-A2 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 2001-11-14 EP claimed
WO-2000047559-A2 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 2000-08-17 WO claimed
EP-1153013-B1 5-HT1F AGONISTS LILLY CO ELI (US) 2007-10-31 EP disclosed
US-6777428-B1 INHIBIT PEPTIDE EXTRAVASATION DUE TO STIMULATION OF THE TRIGEMINAL GANGLIA, AND ARE THEREFORE USEFUL FOR THE TREATMENT OF MIGRAINE AND ASSOCIATED DISORDERS ELI LILLY AND COMPANY 2004-08-17 US disclosed
EP-1153013-A2 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 2001-11-14 EP disclosed
WO-2000047559-A2 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 2000-08-17 WO disclosed